Mondaq USA: Food, Drugs, Healthcare, Life Sciences > Food and Drugs Law
Seyfarth Shaw LLP
One of the hottest topics in the food, beverage and dietary supplement industries, for both producers and advertisers, remains the disclosure of genetically modified organisms, or ‘GMOs,' in these products.
Holland & Knight
On July 14, 2017, Donah Heiberg, with the Bureau of Field Operations for the Florida Agency for Health Care Administration's Office of Health Quality Assurance gave a presentation to District X of the Florida Health Care Association.
Bowditch & Dewey
On July 17th, the Supreme Judicial Court ruled that Massachusetts employers may not terminate an employee merely because of his or her off-site use of medical marijuana.
Ropes & Gray LLP
The United States Food & Drug Administration (FDA) has issued a guidance document announcing its intention not to object to an IRB's waiving or altering the informed consent requirements for an FDA-regulated clinical investigation that presents no more than minimal risk and involves adequate human subjects protections.
Dickinson Wright PLLC
On July 13, the Nevada Tax Commission held a public hearing to discuss the potential marijuana product shortfall facing the state's dispensaries following the launch of state-authorized recreational marijuana sales in Nevada on July 1.
Ogletree, Deakins, Nash, Smoak & Stewart
The court also declined to recognize an action for violation of public policy within the context of adverse employment actions against medical marijuana users.
Reed Smith
The FDA cannot get out of its own way on the issue of off-label communications. Its power to punish off-label promotion comes from an odd regulatory two-step, whereby off-label promotions...
K&L Gates
The Trump administration is considering significant changes relating to the 340B Drug Pricing Program, which allows certain categories of safety net providers to access discounted pricing on covered outpatient drugs from manufacturers.
Seyfarth Shaw LLP
New York state's Medical Marijuana Program historically has been one of the most restrictive in the United States with strict limitations on the number of licensed producers and various barriers preventing...
Reed Smith
A number of governmental entities – states, counties and cities – have sued drug manufacturers, distributors, pharmacists and doctors, alleging that because of their distribution, sales and prescription practices...
Smith Gambrell & Russell LLP
A state judge invalidated New York's so-called "sugary drink" ban, which was to come into effect on March 13, 2013, holding the regulation to be "arbitrary and capricious."
Foley Hoag LLP
In general, the Senate hewed closer to the language and intent of the referendum, while the House repealed the voter-passed law in its entirety in favor of a total rewrite.
Sheppard Mullin Richter & Hampton
In our July 10, 2017 post regarding telemedicine prescribing, we wrote about the seven exceptions to the Haight Act's requirement that a provider and patient have an-person visit before a prescriber/...
Reed Smith
Pennsylvania's burgeoning medical-marijuana industry is and will be carefully regulated. When purchasing insurance, medical-marijuana dispensaries should pay careful attention to the Commonwealth's regulations...
McDermott Will & Emery
A legal challenge to Cook County Illinois Sweetened Beverage Tax (Tax) heads back to circuit court today for a hearing on the plaintiffs' motion for preliminary injunction.
Morrison & Foerster LLP
The Tenth Circuit recently upheld a Utah district court's finding that a branded drug manufacturer could not be held liable for failing to warn consumers about alleged birth defect risks when the FDA...
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
In March, I posted about the Uncertain Future of the 340B Drug Discount Program. When opining about What Could Happen Next I speculated about possible changes to government reimbursement...
Duane Morris LLP
The U.S. Food and Drug Administration has released a draft guidance.
Reed Smith
We depend on young associates to perform most of the legal research that supports the arguments we make on behalf of our clients.
Ford & Harrison LLP
Late last week Florida Governor Rick Scott signed into law a bill intended to implement provisions of the medical marijuana constitutional amendment that was approved by Florida voters last November...
Latest Video
Most Popular Recent Articles
Akin Gump Strauss Hauer & Feld LLP
Despite the headlines coming out of Washington, Congress continues to move forward in regular fashion, discussing and acting upon key issues, such as funding the government, addressing the need...
Arnold & Porter Kaye Scholer LLP
The law also authorizes an additional $500 million over 10 years to an FDA Innovation Account to help the Agency carry out these new authorities.
Duane Morris LLP
On June 8, 2017, Clifford J. White III, director of the U.S. Trustee Program, proclaimed before a congressional subcommittee that "debtors with assets or income derived from marijuana may not proceed...
Schnader Harrison Segal & Lewis LLP
We thought you might be interested in today's U.S. Supreme Court decision Bristol-Myers Squibb Co. v. Superior Court of California.
Hyman, Phelps, & McNamara, P.C.
It's been a couple of months since the dust has settled from FDA's October 26, 2016 approval of Mylan Pharmaceuticals Inc.'s ANDA 078276 for a generic version of Daiichi Sankyo Inc.'s BENICAR Tablets...
Bowditch & Dewey
In Massachusetts, medical marijuana has been legal since 2013. People need only obtain documentation from their physicians certifying that they suffer from a debilitating medical condition...
Reed Smith
Finally, some good news out of California – at least when personal jurisdiction isn't the issue.
Reinhart Boerner Van Deuren S.C.
This seminar presented hot law topics for those in the food and beverage industry, including processors, suppliers, manufacturers, in-house counsel, quality analysis personnel, and insurance consultants.
BakerHostetler
On June 12, 2017, the Supreme Court issued a unanimous opinion in Sandoz v. Amgen, interpreting key provisions of the Biologics Price Competition and Innovation Act in favor of biosimilar manufacturers.
Fisher Phillips LLP
Florida Governor Rick Scott signed a medical marijuana bill into law on Friday that provides guidelines on the implementation of the state's Constitutional Amendment regarding medical marijuana.
Article Search Using Filters
Related Topics
Mondaq Advice Center (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with